LB Pharmaceuticals Inc (LBRX) vs Replimune Group, Inc. (REPL)

LB Pharmaceuticals Inc and Replimune Group, Inc. are both Biotechnology companies. LB Pharmaceuticals Inc and Replimune Group, Inc. are of similar size ($1.2B and $1.2B). Across the 10 metrics below, LB Pharmaceuticals Inc leads on 8 and Replimune Group, Inc. on 2.

Valuation

Metric LBRX REPL Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 3.39 11.37 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (9.22%) (25.40%) (28.84%)
Free cash flow yield (7.36%) (23.36%) (23.03%)

Profitability

Metric LBRX REPL Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (72.07%) (134.29%) (57.72%)
Return on assets (47.38%) (82.28%) (49.22%)
Return on invested capital (1,304.79%) (1,154.69%) 0.00%

Growth

Metric LBRX REPL Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 98.22% (10.10%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LBRX REPL Biotechnology median
Debt to equity 0.00 1.00 0.00
Current ratio 15.08 5.23 4.73
Net debt to EBITDA 9.90 0.51 0.96

Dividend

Metric LBRX REPL Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric LBRX REPL Biotechnology median
Market cap 1.22b 1.20b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack